Showing results (141-150 of 243) with videos related to

Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapyKelly N Blehm, Philippe E Spiess, Jolanta E Bondaruk, et al.
American Journal of Clinical Pathology|April 29, 2016
Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid TumorsRashmi S Goswami, Rajyalakshmi Luthra, Rajesh R Singh, et al.
The American Journal of Surgical Pathology|October 30, 2023
Utility of Immunohistochemistry With Antibodies to SS18-SSX Chimeric Proteins and C-Terminus of SSX Protein for Synovial Sarcoma Differential DiagnosisJerzy Lasota, Małgorzata Chłopek, Maciej Kaczorowski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Phase I study of temozolomide and irinotecan for recurrent malignant gliomas in patients receiving enzyme-inducing antiepileptic drugs: a north american brain tumor consortium studyMonica E Loghin, Michael D Prados, Patrick Wen, et al.
Acta Neuropathologica|February 11, 2012
A prognostic gene expression signature in infratentorial ependymomaKhalida Wani, Terri S Armstrong, Elizabeth Vera-Bolanos, et al.
Neuro-Oncology|August 15, 2014
Clinical course and progression-free survival of adult intracranial and spinal ependymoma patientsElizabeth Vera-Bolanos, Kenneth Aldape, Ying Yuan, et al.
Plos One|March 12, 2014
Molecular subtypes of glioblastoma are relevant to lower grade gliomaXiaowei Guan, Jaime Vengoechea, Siyuan Zheng, et al.
Neuro-Oncology|December 6, 2013
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resectionJason Beiko, Dima Suki, Kenneth R Hess, et al.
Acta Neuropathologica|February 22, 2015
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomasAdriana Olar, Khalida M Wani, Kristin D Alfaro-Munoz, et al.
HGG Advances|August 18, 2023
Complete loss of <i>TP53</i> and <i>RB1</i> is associated with complex genome and low immune infiltrate in pleomorphic rhabdomyosarcomaHannah C Beird, Chia-Chin Wu, Michael Nakazawa, et al.
Pageof 25